Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology. 1995 Jul; 45(7):1277-85. PMID: 7617182. Abstract CommentRecommendBookmarkWatch